1985
DOI: 10.1016/0165-0327(85)90071-0
|View full text |Cite
|
Sign up to set email alerts
|

Cost-benefit analysis of prospective pharmacokinetic dosing of nortriptyline in depressed inpatients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
19
0

Year Published

1994
1994
2016
2016

Publication Types

Select...
3
3

Relationship

0
6

Authors

Journals

citations
Cited by 36 publications
(20 citation statements)
references
References 4 publications
1
19
0
Order By: Relevance
“…Some studies calculated a benefit/cost ratio. For example, Simmons et al 75 indicated the relation between the input and output of services.…”
Section: Nature Of Economic Appraisalmentioning
confidence: 98%
See 3 more Smart Citations
“…Some studies calculated a benefit/cost ratio. For example, Simmons et al 75 indicated the relation between the input and output of services.…”
Section: Nature Of Economic Appraisalmentioning
confidence: 98%
“…The remaining studies specified the evaluation of only part of the costs, 79,96,118,123,130,151 estimated the costs 1,[64][65][66]112,140,152 or their method of evaluation was unclear. 64,65,67,69,71,75,99,100,109,119,127 About 9% of the studies reviewed explicitly mention the valuation of indirect costs. All the studies which actually gave a value to indirect costs used earnings.…”
Section: Measurement Of Costsmentioning
confidence: 99%
See 2 more Smart Citations
“…TDM has been reported to increase not only efficacy and safety of TCAs, but also cost-effectiveness in the treatment of depression and is highly recommended for most tricyclic antidepressants. It reduces the risk of intoxication, and for many TCAs, a plasma concentration-clinical effectiveness relationship has been shown [5][6][7][8][9] . These older agents are limited by their greater risk of overdose, potential effects on cardiac conduction/arrythmias (TCAs), and substantial restrictions on diet and medications (MAOIs).…”
Section: Tricyclic Antidepressants and Monoamine Oxidase Inhibitorsmentioning
confidence: 99%